382 Results

People

  1. Larson
    Larson
  2. Finn
    Finn
  3. Humm
    Humm
  4. Sgouros
    Sgouros
  5. Blasberg
    Blasberg
  6. Zanzonico
    Zanzonico
  7. Yeung
    Yeung
  8. Gelovani
    Gelovani
  9. Macapinlac
    Macapinlac
  10. Schoder
    Schoder

Groups

  1. Radiology, Department of (276)
  2. Molecular Imaging and Therapy Service (227)
  3. GSK Faculty (220)
  4. Sloan Kettering Institute Faculty (195)
  5. Molecular Pharmacology and Chemistry Program Faculty (193)
  6. Medical Physics (122)
  7. Sloan Kettering Institute Postdocs (95)
  8. Department of Medicine (81)
  9. Radiochemistry and Imaging Sciences Service (81)
  10. Solid Tumor Oncology Division (45)
  1. "Meeting abstract"
  2. "Journal of Nuclear Medicine"
Formats
  1. Meeting Abstract (382)
Groups
  1. Radiology, Department of (276)
  2. Molecular Imaging and Therapy Service (227)
  3. GSK Faculty (220)
  4. Sloan Kettering Institute Faculty (195)
  5. Molecular Pharmacology and Chemistry Program Faculty (193)
  6. Medical Physics (122)

More Groups

People
  1. Steven Larson (150)
  2. Ronald Finn (65)
  3. John Humm (48)
  4. George Sgouros (46)
  5. Ronald Blasberg (39)
  6. Pat Zanzonico (37)

More People

Years
  1. 2023 (28)
  2. 2022 (3)
  3. 2021 (8)
  4. 2020 (20)
  5. 2019 (32)
  6. 2017 (21)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
Publishers
  1. Society of Nuclear Medicine (382)

Results (382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • International benchmark for total metabolic tumor volume assessment in baseline FDG PET/CT of lymphoma patients
    Meeting Abstract

    Boellaard, R.; Buvat, I.; Ceriani, L.; Cottereau, A. S.; Guerra, L.; Hicks, R.; Kanoun, S.; Kobe, C.; Loft, A.; Schoder, H.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Individualized dosing for high-dose targeted radiation of hematopoietic cells with Iomab-B (I131-apamistamab) prior to HCT in relapsed/refractory acute myeloid leukemia (R/R AML): Safety and efficacy results from the pivotal phase 3 SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Mhlanga, J.; Wahl, R.; Avril, N.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • 89Zr-DFO-girentuximab PET/CT imaging can accurately detect clear cell renal cell carcinoma primary and secondary lesions in patients with renal masses at conventional imaging, results from ZIRCON phase 3 study
    Meeting Abstract

    Calais, J.; Shuch, B.; Pantuck, A.; Bernhard, J. C.; Morris, M.; Master, V.; Scott, A.; van Praet, C.; Bailly, C.; Aksoy, T.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Dose-escalation study of [225Ac]-FPI-1434 (FPI-1434) in patients (pts) with IGF-1R expressing advanced solid tumors: Preliminary pharmacology and dosimetry results
    Meeting Abstract

    Pandit-Taskar, N.; Wong, J.; Subbiah, V.; Chenard-Poirier, M.; Pryma, D.; Berlin, A.; Juergens, R.; Puzanov, I.; Jacene, H.; Schindler, J.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • The PET raw data standardization initiative
    Meeting Abstract

    Thielemans, K.; Asma, E.; Cook, M.; Hansen, M.; Jones, J.; Karakatsanis, N.; Kesner, A.; Leung, E.; Markiewicz, P.; Prevrhal, S.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Administration and radiation safety of high-dose Iomab-B (I131-apamistamab) demonstrated in multiple clinical settings: Experience from the large multicenter phase 3 SIERRA trial for targeted conditioning of patients with relapsed/refractory AML
    Meeting Abstract

    Serencsits, B.; Prasad, K.; Chen, L.; Senglaub, T.; Zgaljardic, M.; Brodin, P.; McNamara, K.; Desai, A.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • A novel model-based planar reconstruction method for accurate activity distribution estimation for 225Ac-PSMA targeted alpha therapy
    Meeting Abstract

    Schmidtlein, C.; Ren, J.; Krol, A.; O'Donoghue, J.; Gifford, H.; Bodei, L.; Lafontaine, D.; Zechowy, D.; Xu, Y.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Streamlining personalized dosimetry for I131-apamistamab using a Co-57 sheet source to circumvent the need for radionuclide-specific attenuation correction
    Meeting Abstract

    Schwartz, J.; Brodin, P.; Spross, J.; Haeuber, E.; Fisher, D.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Comparison of MIRDfit and MIRDcalc tools with commercial software for dosimetry in radiopharmaceutical therapy
    Meeting Abstract

    Ramos, J. O.; Ramirez, E. M.; Carter, L.; Marquis, H.; Kesner, A.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • MIRD synopsis for dosimetry in radiopharmaceutical therapies: A case study for currently approved (177)Lu therapies
    Meeting Abstract

    Uribe, C.; Howell, R.; Kesner, A.; Adhikarla, V.; Bolch, W.; Dewaraja, Y.; Erwin, W.; Fisher, D.; Laforest, R.; Sgouros, G.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save